does tirzepatide make your skin hurt If hurts to touch while on GLP-1, you're not imagining it. A new case series documents allodynia as a dose-dependent side effect of GLP-1 medications. Here's what we know so far. Injection site reaction too serious

For specific milligram-to-unit conversions, these guides cover the most common scenarios: 2.5 mg in units , 5 mg in units , 7.5 mg in units , 10 mg in units , 12.5 mg in units , and 15 mg in units

individual results vary significantly Both medications require adherence to dosing schedule and lifestyle modifications Higher doses generally produce better results but may have more side effects Not everyone reaches maximum doses due to side effect tolerance Actual weight loss depends on starting weight, diet, exercise, and individual metabolism Time to See Results: Semaglutide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (5-8 pounds) Weeks 12-24: Steady weight loss (1-2 pounds per week) Weeks 24-68: Continued weight loss at slower pace Tirzepatide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (8-12 pounds) Weeks 12-24: Steady weight loss (1.5-2.5 pounds per week) Weeks 24-72: Continued weight loss, often at sustained pace Both medications show continued weight loss throughout the clinical trial periods, with weight loss plateauing around month 16-20 for most participants

Common dosing mistakes with 20mg/ml tirzepatide After analyzing the most frequent questions and errors people report, these are the specific mistakes that happen repeatedly with the 20mg/ml concentration

Compounded Semaglutide: According to the company, starting at approximately $159 per month as of March 2026

This consideration becomes less relevant as patients gain confidence and experience with self-administration

MEDVi : Best for Fast Approvals & Required Provider Follow-Ups Best for Fast Approvals & Required Provider Follow-Ups MEDVi offers compounded semaglutide and tirzepatide with required monthly provider follow-ups, which sets it apart from clinics with minimal clinical oversight